GaAs-IR-Lumineszenzdiode GaAs Infrared Emitter SFH 409 Wesentliche Merkmale Features * * * * GaAs-LED mit sehr hohem Wirkungsgrad Hohe Zuverlassigkeit Hohe Impulsbelastbarkeit Gute spektrale Anpassung an Si-Fotoempfanger * Gehausegleich mit SFH 309, SFH 487 * * * * * Anwendungen Applications * IR-Fernsteuerungen von Fernseh-, Rundfunkund Videogeraten, Lichtdimmern * Lichtschranken bis 500 kHz * Munzzahler * Sensorik * Diskrete Optokoppler * IR remote control for hifi and TV sets, video tape recorders, dimmers * Light-reflection switches (max. 500 kHz) * Coin counters * Sensor technology * Discrete optocouplers Very highly efficient GaAs-LED High reliability High pulse handling capability Good spectral match to silicon photodetectors Same package as SFH 309, SFH 487 Typ Type Bestellnummer Ordering Code Gehause Package SFH 409 Q62702-P860 SFH 409-2 Q62702-P1002 3-mm-LED-Gehause (T 1), grau eingefarbt, Anschlusse im 2.54-mm-Raster (1/10''), Kathodenkennzeichnung: kurzerer Anschlu 3 mm LED package (T 1), grey-colored epoxy resin, solder tabs lead spacing 2.54 mm (1/10''), cathode marking: short lead 2001-02-22 1 SFH 409 Grenzwerte (TA = 25 C) Maximum Ratings Bezeichnung Parameter Symbol Symbol Wert Value Einheit Unit Betriebs- und Lagertemperatur Operating and storage temperature range Top; Tstg - 40 ... + 100 C Sperrspannung Reverse voltage VR 5 V Durchlastrom Forward current IF 100 mA Stostrom, 10 s, D = 0 Surge current IFSM 3 A Verlustleistung Power dissipation Ptot 165 mW Warmewiderstand Thermal resistance RthJA 450 K/W Bezeichnung Parameter Symbol Symbol Wert Value Einheit Unit Wellenlange der Strahlung Wavelength at peak emission IF = 100 mA, tp = 20 ms peak 950 nm Spektrale Bandbreite bei 50% von Imax Spectral bandwidth at 50% of Imax IF = 100 mA, tp = 20 ms 55 nm Abstrahlwinkel Half angle 20 Grad deg. Aktive Chipflache Active chip area A 0.09 mm2 Abmessungen der aktiven Chipflache Dimensions of the active chip area LxB LxW 0.3 x 0.3 mm Abstand Chipoberflache bis Linsenscheitel Distance chip surface to lens top H 2.6 mm Kapazitat, VR = 0 V Capacitance Co 25 pF Kennwerte (TA = 25 C) Characteristics 2001-02-22 2 SFH 409 Kennwerte (TA = 25 C) Characteristics (cont'd) Bezeichnung Parameter Symbol Symbol Wert Value Einheit Unit Schaltzeiten, Ie von 10% auf 90% und von 90% auf 10%, bei IF = 100 mA, RL = 50 Switching times, e from 10% to 90% and from 90% to 10%, IF = 100 mA, RL = 50 tr, tf 0.5 s VF VF 1.30 ( 1.5) 1.9 ( 2.5) V V Sperrstrom, Reverse current, VR = 5 V IR 0.01 ( 1) A Gesamtstrahlungsflu, Total radiant flux IF = 100 mA, tp = 20 ms e 15 mW Temperaturkoeffizient von Ie bzw. e, IF = 100 mA Temperature coefficient of Ie or e, IF = 100 mA TCI - 0.55 %/K Temperaturkoeffizient von VF, IF = 100 mA Temperature coefficient of VF, IF = 100 mA TCV - 1.5 mV/K Temperaturkoeffizient von peak, IF = 100 mA Temperature coefficient of peak, IF = 100 mA TC + 0.3 nm/K Durchlaspannung, Forward voltage IF = 100 mA, tp = 20 ms IF = 1 A, tp = 100 s Gruppierung der Strahlstarke Ie in Achsrichtung gemessen bei einem Raumwinkel = 0.01 sr Grouping of Radiant Intensity Ie in Axial Direction at a solid angle of = 0.01 sr Bezeichnung Parameter Strahlstarke Radiant intensity IF = 100 mA, tp = 20 ms IF = 1 A, tp = 100 s 1) Nur auf Anfrage lieferbar. 1) Available only on request. 2001-02-22 Symbol Ie Ie typ. Werte Values Einheit Unit SFH 409 SFH 409-11) SFH 409-2 SFH 409-3 6.3 - 6.3 ... 12.5 75 > 10 120 16 ... 32 - 3 mW/sr mW/sr SFH 409 Relative Spectral Emission Irel = f () Radiant Intensity Single pulse, tp = 20 s e (100 mA) 10 1 % rel OHR00864 e OHR01938 100 e = f (IF ) e 100 mA Max. Permissible Forward Current IF = f (T A ) OHR00883 120 I F mA 100 80 80 60 RthjA = 450 K/W 60 10 0 40 40 20 20 0 880 920 960 1000 nm 10 -1 10 -2 1060 IF 10 0 10 4 OHR01041 OHR00865 D= T IF T D = 0.005 typ. max. 0.01 0.02 10 5 10 -1 0.05 3 0.1 0.2 0.5 10 -2 1 1.5 2 2.5 3 3.5 DC 10 2 10 -5 10 -4 10 -3 10 -2 10 -1 10 0 10 1 s 10 2 4 V 4.5 VF Radiation Characteristics rel = f () 40 30 20 10 0 OHR01887 1.0 50 0.8 60 0.6 70 0.4 0.2 80 0 90 100 1.0 2001-02-22 0.8 0.6 0.4 0 20 40 60 80 4 100 0 0 20 40 60 80 100 C 120 TA I F mA 5 10 0 10 1 A F Permissible Pulse Handling Capability IF = f (), TA = 25 C duty cycle D = parameter Forward Current IF = f (VF), Single pulse, tp = 20 s 10 1 A 10 -1 120 SFH 409 Mazeichnung Package Outlines 5.2 (0.205) 2.54 (0.100) spacing 1.8 (0.071) 1.2 (0.047) 0.7 (0.028) 0.4 (0.016) 0.8 (0.031) 0.4 (0.016) Area not flat 0.6 (0.024) 0.4 (0.016) 4.1 (0.161) 3.9 (0.154) o3.1 (0.122) o2.9 (0.114) 4.5 (0.177) 4.0 (0.157) 3.6 (0.142) (3.5 (0.138)) 6.3 (0.248) 29 (1.142) 27 (1.063) 5.9 (0.232) Chip position Cathode (SFH 409, SFH 4332) Anode (SFH 487, SFH 4301) 0.4 (0.016) GEXY6250 Mae werden wie folgt angegeben: mm (inch) / Dimensions are specified as follows: mm (inch). Published by OSRAM Opto Semiconductors GmbH & Co. OHG Wernerwerkstrasse 2, D-93049 Regensburg (c) All Rights Reserved. Attention please! The information describes the type of component and shall not be considered as assured characteristics. Terms of delivery and rights to change design reserved. Due to technical requirements components may contain dangerous substances. For information on the types in question please contact our Sales Organization. Packing Please use the recycling operators known to you. We can also help you - get in touch with your nearest sales office. By agreement we will take packing material back, if it is sorted. You must bear the costs of transport. For packing material that is returned to us unsorted or which we are not obliged to accept, we shall have to invoice you for any costs incurred. Components used in life-support devices or systems must be expressly authorized for such purpose! Critical components 1 , may only be used in life-support devices or systems 2 with the express written approval of OSRAM OS. 1 A critical component is a component usedin a life-support device or system whose failure can reasonably be expected to cause the failure of that life-support device or system, or to affect its safety or effectiveness of that device or system. 2 Life support devices or systems are intended (a) to be implanted in the human body, or (b) to support and/or maintain and sustain human life. If they fail, it is reasonable to assume that the health of the user may be endangered. 2001-02-22 5